Research article
Connective tissue proliferation and growth factors in animal models of Duchenne muscular dystrophy

https://doi.org/10.1016/0022-510X(94)00219-EGet rights and content

Abstract

The difference in the lifespan of dy and mdx mice could be due to different muscle regeneration capabilities. In mdx an involvement of bFGF in stimulating regeneration has been postulated. The aim of our work was to detect the presence, and to study the distribution, of muscular and connective tissue growth factors in mdx and dy mice at different stages of muscle pathology. From 7 to 10 weeks of age the difference between the two dystrophic mice becomes evident. At 13 weeks the dy mouse presents a predominance of fibrosis and degenerative muscular phenomena while the main pathological feature in mdx mouse is the muscle regeneration. In both animal models fibrosis proliferation is correlated to the presence of EGF and its receptor and TGFβ1. bFGF was localized to regenerating and degenerating fibers in both dy and mdx mice. The bFGF presented a normal pattern in mdx mice at 20 weeks when regenerative and degenerative phenomena were no longer present. Our data suggest that growth factors could influence the outcome of muscular regenerative and degenerative processes.

References (28)

  • J.L. Carpenter et al.

    Feline muscular dystrophy with dystrophin deficiency

    Am. J. Pathol.

    (1989)
  • P.A. D'Amore et al.

    Elevated bFGF in the serum of patients with DMD

    Ann. Neurol.

    (1994)
  • J. DiMario et al.

    Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle

    Science

    (1989)
  • V. Dubowitz

    Muscle Biopsy: A practical approach

    (1985)
  • Cited by (28)

    • Treatment and Management of Muscular Dystrophies

      2021, Neuromuscular Disorders: Treatment and Management
    • Treatment and Management of Muscular Dystrophies

      2010, Neuromuscular Disorders: Treatment and Management
    • Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice

      2007, Neuromuscular Disorders
      Citation Excerpt :

      Since the mdx mouse is not severely crippled [12], has less fibrosis and more central nuclei than human DMD [10,17,18], we postulated that there may be additional compensatory molecular pathways or modifier genes in the mdx mouse that warrant further investigation. Disease-modifying factors implicated in the mdx mouse have been described [19], such as extra-cellular matrix alterations [20–23], naturally occurring and experimental up-regulation of utrophin [24–27], myostatin inhibition [28,29], calcium protein-handling protein(s) [30–32] and enhanced satellite cell function and regeneration [33–37]. While some of these modifiers are likely important in making the mdx phenotype relatively benign, many of these samemdx changes are occurring in parallel with DMD [2,12,38,39] and cannot fully account for the clear discordant phenotypic severity.

    • Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: A role for osteopontin

      2003, American Journal of Pathology
      Citation Excerpt :

      Most of them are also recognized to be increased at 96 hours after muscle injury and are related to maturation of regenerating myofibers or tissue remodeling. Throughout the period examined, the gene expressions of epidermal growth factor, transforming growth factor-β1, and FGF-2, which correlate with fibrotic changes of diseased muscle,32–34 were not highly up-regulated. Our array experiments showed that the OPN gene was one of the most prominently up-regulated genes (Tables 1 and 4).

    View all citing articles on Scopus
    View full text